Population Health Sciences

You are here

Publications

Found 308 results

Author Title [ Type

] Year

Filters: First Letter Of Last Name is B [Clear All Filters]

Journal Article

Borden WB, Mushlin AI, Gordon JE, Leiman JM, Pardes H. 2015. A new conceptual framework for academic health centers.. Acad Med. 90(5):569-73.

Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T et al.. 2019. No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations.. Ann Surg. 269(2):211-220.

Hirst A, Philippou Y, Blazeby J, Campbell B, Campbell M, Feinberg J, Rovers M, Blencowe N, Pennell C, Quinn T et al.. 2019. No Surgical Innovation Without Evaluation: Evolution and Further Development of the IDEAL Framework and Recommendations.. Ann Surg. 269(2):211-220.

Murthy SB, Wu X, Díaz I, Parasram M, Parikh NS, Iadecola C, Merkler AE, Falcone GJ, Brown S, Biffi A et al.. 2020. Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events.. Stroke. 51(5):1464-1469.

Murthy SB, Wu X, Díaz I, Parasram M, Parikh NS, Iadecola C, Merkler AE, Falcone GJ, Brown S, Biffi A et al.. 2020. Non-Traumatic Subdural Hemorrhage and Risk of Arterial Ischemic Events.. Stroke. 51(5):1464-1469.

Xu H, Buckeridge DL, Wang F, Tarczy-Hornoch P. 2022. Novel informatics approaches to COVID-19 Research: From methods to applications.. J Biomed Inform. 129:104028.

Unruh MAaron, Yun H, Zhang Y, Braun RT, Jung H-Y. 2020. Nursing Home Characteristics Associated With COVID-19 Deaths in Connecticut, New Jersey, and New York.. J Am Med Dir Assoc. 21(7):1001-1003.

Turchioe MReading, Grossman LV, Baik D, Lee CS, Maurer MS, Goyal P, Safford MM, Creber RMMasterso. 2020. Older Adults Can Successfully Monitor Symptoms Using an Inclusively Designed Mobile Application.. J Am Geriatr Soc.

Hupert N, Biala K, Holland T, Baehr A, Hasan A, Harvey M. 2015. Optimizing Health Care Coalitions: Conceptual Frameworks and a Research Agenda.. Disaster Med Public Health Prep. 9(6):717-23.

Hupert N, Biala K, Holland T, Baehr A, Hasan A, Harvey M. 2015. Optimizing Health Care Coalitions: Conceptual Frameworks and a Research Agenda.. Disaster Med Public Health Prep. 9(6):717-23.

Cea ME, M Reid C, Inturrisi C, Witkin LR, Prigerson HG, Bao Y. 2016. Pain Assessment, Management, and Control Among Patients 65 Years or Older Receiving Hospice Care in the U.S.. J Pain Symptom Manage. 52(5):663-672.

Bao Y, Fan G, Zou D, Wang T, Xue D. 2017. Patient experience with outpatient encounters at public hospitals in Shanghai: Examining different aspects of physician services and implications of overcrowding.. PLoS One. 12(2):e0171684.

Mullangi S, Bhandari R, Thanaporn P, Christensen M, Kronick S, Nallamothu BK. 2020. Perceptions of resuscitation care among in-hospital cardiac arrest responders: a qualitative analysis.. BMC Health Serv Res. 20(1):145.

Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X et al.. 2019. A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.. Blood. 133(11):1201-1204.

Martin P, Bartlett NL, Blum KA, Park S, Maddocks K, Ruan J, Ridling LA, Dittus C, Chen Z, Huang X et al.. 2019. A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma.. Blood. 133(11):1201-1204.

Tagawa ST, Vallabhajosula S, Christos PJ, Jhanwar YS, Batra JS, Lam L, Osborne J, Beltran H, Molina AM, Goldsmith SJ et al.. 2019. Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( Lu-J591) for metastatic castration-resistant prostate cancer.. Cancer. 125(15):2561-2569.

Tagawa ST, Vallabhajosula S, Christos PJ, Jhanwar YS, Batra JS, Lam L, Osborne J, Beltran H, Molina AM, Goldsmith SJ et al.. 2019. Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( Lu-J591) for metastatic castration-resistant prostate cancer.. Cancer. 125(15):2561-2569.

Tagawa ST, Vallabhajosula S, Christos PJ, Jhanwar YS, Batra JS, Lam L, Osborne J, Beltran H, Molina AM, Goldsmith SJ et al.. 2019. Phase 1/2 study of fractionated dose lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 ( Lu-J591) for metastatic castration-resistant prostate cancer.. Cancer. 125(15):2561-2569.

Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al.. 2020. Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.

Batra JS, Niaz MJunaid, Whang YE, Sheikh A, Thomas C, Christos P, Vallabhajosula S, Jhanwar YS, Molina AM, Nanus DM et al.. 2020. Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (Lu-J591) for metastatic castration-resistant prostate cancer.. Urol Oncol.

Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al.. 2019. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.

Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al.. 2019. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.

Beltran H, Oromendia C, Danila DC, Montgomery B, Hoimes C, Szmulewitz RZ, Vaishampayan U, Armstrong AJ, Stein M, Pinski J et al.. 2019. A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.. Clin Cancer Res. 25(1):43-51.

Jung H-Y, Unruh MAaron, Vest JR, Casalino LP, Kern LM, Grinspan ZM, Bao Y, Kaushal R. 2017. Physician Participation in Meaningful Use and Quality of Care for Medicare Fee-for-Service Enrollees.. J Am Geriatr Soc. 65(3):608-613.

Gupta A, Kesavabhotla K, Baradaran H, Kamel H, Pandya A, Giambrone AE, Wright D, Pain KJ, Mtui EE, Suri JS et al.. 2015. Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis.. Stroke. 46(1):91-7.